Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Animal modeling an oligodendrogliopathy - multiple system atrophy.
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.
Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.
Charles bonnet syndrome after herpes simplex encephalitis.
Evidence of Oxidative Stress in Very Long Chain Fatty Acid - Treated Oligodendrocytes and Potentialization of Ros Production Using Rna Interference Directed Knockdown of Abcd1 and Acox1 Peroxisomal Proteins.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: Evidence for their involvement in regulation of the viral DNA replication.
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Adjudin - a Male Contraceptive with Other Biological Activities.
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
[Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France].
Reliability and Repeatability of the Hoffmann Sign.
Coping and its importance for quality of life in patients with multiple sclerosis.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Pages
« first
‹ previous
…
694
695
696
697
698
699
700
701
702
…
next ›
last »